AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 22 min read$AXON

Kalinowski Caitlin Elizabeth sold $77K of AXON

Kalinowski Caitlin Elizabeth sold 160 shares of AXON ENTERPRISE, INC. (AXON) at $482.93 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

This adds incremental sentiment information for AXON but does not introduce new company fundamentals (earnings, guidance, contracts, litigation, or product/drug trial results).

02

Market read

Use as a small sentiment/positioning input; treat as low-impact unless corroborated by broader insider selling trends or other catalysts.

03

What to watch

No 10b5-1 plan is stated, but Form 4s can still reflect pre-planned schedules or personal needs; traders should check for prior insider transactions and overall insider net activity.

Relevance 4/10Novelty 6/10Timing: After-hours/next-session read-through from a newly filed Form 4 (filed 2026-06-02).

Background

The article is an SEC Form 4 insider transaction disclosure for Axon Enterprise (AXON), reporting an open-market sale by a director.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon Enterprise director Caitlin Kalinowski sold 160 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-01.

Expected impact

Low near-term impact; any effect is likely limited to short-lived sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing provides a discrete sale size and price but no accompanying company-specific operational or financial change.

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide policy or regulatory change mentioned.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Director selling can be routine liquidity management; without evidence of a pattern or linkage to performance, the market may discount it quickly.

Key entities

  • issuer
    AXON ENTERPRISE, INC.

    Public company whose director insider sale is disclosed on SEC Form 4.

  • director
    Caitlin Elizabeth Kalinowski

    Director who sold 160 shares at $482.93/share on 2026-06-01.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AXON insider trading history →

Related articles

AUG 23
$AXONMedAI 8/10

Axon’s AI Era Revenue Jumped Nearly 700%. Here’s What’s Behind It

Axon Enterprise (AXON) reported 35% revenue growth to $904M, beating estimates. AI Era revenue surged nearly 700% YoY. Management raised full-year guidance to 32-34% growth. Gross margin slipped 40 basis points to 62.9%. Analysts estimate a target price of $714, implying 13.7% upside over 2.4 years. The stock trades at 70x forward earnings, with growth driven by software and AI products.

tikr.com3 min
AUG 20
$BABAHighAI 8/10

Breakfast News: Alibaba's AI Push Comes at a Cost

Alibaba's Q1 revenue rose 9% to $39.6B, but operating income fell 57% due to tech investments. BILL Holdings reported 14% revenue growth and 80% operating income increase. U.S. debt surpassed $40T, with Treasury buybacks easing yield pressure. Apple plans 2027 launch for camera AirPods. Axon Enterprise passes competitive position tests, with a 69% potential upside to $1,088.08.

fool.com4 min
AUG 10
$AXONMed

Axon Stock Rebounds As Its Margin Squeeze Looks Like The Price Of Growth

Axon Enterprise (AXON) shares rose 9.3% on Friday after a 14.3% drop the prior session following its Q2 2026 results. The quarter showed revenue of $904 million, up 35% year over year, and a raised full-year outlook. The market disagreed over margin compression tied to higher memory costs and counter-drone hardware mix, with Axon expecting Q3 adjusted EBITDA margin to hold and rebuild in Q4.

finance.yahoo.com4 min
AUG 7
$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

aol.com4 min